WCLC 2022 Conference Coverage


 

Sotorasib in Combination With RMC-4630, a SHP2 Inhibitor, in KRAS p.G12C-Mutated NSCLC and Other Solid Tumors

149 views
September 16, 2022
Comments 0
Login to view comments. Click here to Login